Scientific publications
Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network
José Antonio López-Guerrero 1 2 3 , Marta Mendiola 4 5 , José Alejandro Pérez-Fidalgo 6 , Ignacio Romero 7 , Ana Torres 8 , Delia Recalde 9 , Elena Molina 10 , César Gómez-Raposo 11 , Ana M Levin 12 , Ana Herrero 13 , Jesús Alarcón 14 , Carmen Esteban 15 , Gloria Marquina 16 , María Jesús Rubio 17 , Eva Guerra 18 , Luisa Sánchez-Lorenzo 19 , Fernando Gálvez-Montosa 20 , Ana de Juan 21 , Cristina Churruca 22 , Alejandro Gallego 23 , Antonio González-Martín 19 24
Abstract
Patient registries linked to biorepositories constitute a valuable asset for clinical and translational research in oncology. The Spanish Group of Ovarian Cancer Research (GEICO), in collaboration with the Spanish Biobank Network (RNBB), has developed a multicentre, multistakeholder, prospective virtual clinical registry (VCR) associated with biobanks for the collection of real-world data and biological samples of gynaecological cancer patients.
This collaborative project aims to promote research by providing broad access to high-quality clinical data and biospecimens for future research according to the needs of investigators and to increase diagnostic and therapeutic opportunities for gynaecological cancer patients in Spain.
The VCR will include the participation of more than 60 Spanish hospitals entering relevant clinical information in harmonised electronic case report forms (eCRFs) in four different cohorts: ovarian, endometrial, cervical, and rare gynaecological cancers (gestational trophoblastic disease). Initial data for the cases included till December 2021 are presented.
The model described herein establishes a real-world win-win collaboration between multicentre structures, promoted and supported by GEICO, that will contribute to the success of translational research in gynaecological cancer.
CITATION Cancers (Basel). 2022 Apr 13;14(8):1965. doi: 10.3390/cancers14081965
